{"DataElement":{"publicId":"4908817","version":"1","preferredName":"Kidney Neoplasm Histologic Subtype Diagnosis Renal Diagnosis Type","preferredDefinition":"Information related to the concise results of scientific determination or investigation pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues of or pertaining to a benign or malignant neoplasm affecting the kidney.","longName":"RnlHstDxTp","context":"COG","contextVersion":"1","DataElementConcept":{"publicId":"4908777","version":"1","preferredName":"Kidney Neoplasm Histologic Subtype Diagnosis","preferredDefinition":"Information related to the concise results of scientific determination or investigation pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues of or pertaining to a benign or malignant neoplasm affecting the kidney.","longName":"RnlHstDx","context":"COG","contextVersion":"1","ObjectClass":{"publicId":"4908876","version":"1","preferredName":"Kidney Neoplasm","preferredDefinition":"A benign or malignant neoplasm affecting the kidney. Representative examples of benign renal neoplasms include fibroma, lipoma, oncocytoma, and juxtaglomerular cell tumor. Representative examples of malignant renal neoplasms include renal cell carcinoma, renal pelvis carcinoma, Wilms tumor, rhabdoid tumor, sarcoma, and lymphoma.","longName":"C3150","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Kidney Neoplasm","conceptCode":"C3150","definition":"A benign or malignant neoplasm affecting the kidney. Representative examples of benign renal neoplasms include fibroma, lipoma, oncocytoma, and juxtaglomerular cell tumor. Representative examples of malignant renal neoplasms include renal cell carcinoma, renal pelvis carcinoma, Wilms tumor, rhabdoid tumor, sarcoma, and lymphoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B546673-AC0B-9D7F-E050-BB89AD434516","latestVersionIndicator":"Yes","beginDate":"2015-07-20","endDate":null,"createdBy":"TSANE","dateCreated":"2015-07-20","modifiedBy":"ONEDATA","dateModified":"2015-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"4908877","version":"1","preferredName":"Histologic Subtype Diagnosis","preferredDefinition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.:A group forming a type within a larger type.:The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","longName":"C25526:C25696:C15220","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Subtype","conceptCode":"C25696","definition":"A group forming a type within a larger type.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B546673-AC1D-9D7F-E050-BB89AD434516","latestVersionIndicator":"Yes","beginDate":"2015-07-20","endDate":null,"createdBy":"TSANE","dateCreated":"2015-07-20","modifiedBy":"ONEDATA","dateModified":"2015-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"COG CRF:Children's Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B54A9C6-CDDA-EEB8-E050-BB89AD436D43","latestVersionIndicator":"Yes","beginDate":"2015-07-20","endDate":null,"createdBy":"TSANE","dateCreated":"2015-07-20","modifiedBy":"MAESKEB","dateModified":"2019-10-21","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"4908798","version":"1","preferredName":"Renal Diagnosis Type","preferredDefinition":"Information related to the type of identifiable class based on common qualities resulting from the investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms.","longName":"RnlDxTp","context":"COG","contextVersion":"1","type":"Enumerated","dataType":"ALPHANUMERIC","minLength":null,"maxLength":"150","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Rhabdoid Tumor (outside the CNS)","valueDescription":"Rhabdoid Tumor (outside the CNS)","ValueMeaning":{"publicId":"4908799","version":"1","preferredName":"Rhabdoid Tumor (outside the CNS)","longName":"4908799","preferredDefinition":"Rhabdoid Tumor (outside the CNS)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B546673-A7B9-9D7F-E050-BB89AD434516","latestVersionIndicator":"Yes","beginDate":"2015-07-20","endDate":null,"createdBy":"TSANE","dateCreated":"2015-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B546673-A7D2-9D7F-E050-BB89AD434516","beginDate":"2015-07-20","endDate":null,"createdBy":"TSANE","dateCreated":"2015-07-20","modifiedBy":"ONEDATA","dateModified":"2015-07-20","deletedIndicator":"No"},{"value":"Other","valueDescription":"Other","ValueMeaning":{"publicId":"2946060","version":"1","preferredName":"Other","longName":"2946060","preferredDefinition":"Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"746A8063-D650-3C9D-E040-BB89AD437A9B","latestVersionIndicator":"Yes","beginDate":"2009-09-25","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-25","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":"1/25/23 added alt name for ticket number CADSR0001948 for CCTG cjl.","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B546673-A7AF-9D7F-E050-BB89AD434516","beginDate":"2015-07-20","endDate":null,"createdBy":"TSANE","dateCreated":"2015-07-20","modifiedBy":"ONEDATA","dateModified":"2015-07-20","deletedIndicator":"No"},{"value":"Renal tumors associated with TFE3 or TFEB translocations","valueDescription":"Renal tumors associated with TFE3 or TFEB translocations","ValueMeaning":{"publicId":"4908800","version":"1","preferredName":"Renal tumors associated with TFE3 or TFEB translocations","longName":"4908800","preferredDefinition":"Renal tumors associated with TFE3 or TFEB translocations","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B546673-A7DC-9D7F-E050-BB89AD434516","latestVersionIndicator":"Yes","beginDate":"2015-07-20","endDate":null,"createdBy":"TSANE","dateCreated":"2015-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B546673-A7F5-9D7F-E050-BB89AD434516","beginDate":"2015-07-20","endDate":null,"createdBy":"TSANE","dateCreated":"2015-07-20","modifiedBy":"ONEDATA","dateModified":"2015-07-20","deletedIndicator":"No"},{"value":"Renal medullary carcinoma","valueDescription":"Renal medullary carcinoma","ValueMeaning":{"publicId":"4908801","version":"1","preferredName":"Renal medullary carcinoma","longName":"4908801","preferredDefinition":"Renal medullary carcinoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B546673-A7FF-9D7F-E050-BB89AD434516","latestVersionIndicator":"Yes","beginDate":"2015-07-20","endDate":null,"createdBy":"TSANE","dateCreated":"2015-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B546673-A818-9D7F-E050-BB89AD434516","beginDate":"2015-07-20","endDate":null,"createdBy":"TSANE","dateCreated":"2015-07-20","modifiedBy":"ONEDATA","dateModified":"2015-07-20","deletedIndicator":"No"},{"value":"Renal cell carcinoma, other","valueDescription":"Renal cell carcinoma, other","ValueMeaning":{"publicId":"4908802","version":"1","preferredName":"Renal cell carcinoma, other","longName":"4908802","preferredDefinition":"Renal cell carcinoma, other","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B546673-A822-9D7F-E050-BB89AD434516","latestVersionIndicator":"Yes","beginDate":"2015-07-20","endDate":null,"createdBy":"TSANE","dateCreated":"2015-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B546673-A83B-9D7F-E050-BB89AD434516","beginDate":"2015-07-20","endDate":null,"createdBy":"TSANE","dateCreated":"2015-07-20","modifiedBy":"ONEDATA","dateModified":"2015-07-20","deletedIndicator":"No"},{"value":"Papillary renal cell carcinoma","valueDescription":"Papillary Renal Cell Carcinoma","ValueMeaning":{"publicId":"2581626","version":"1","preferredName":"Papillary Renal Cell Carcinoma","longName":"2581626","preferredDefinition":"Also known as chromophil carcinoma, it represents a minority of renal cell carcinomas.  It can be hereditary or sporadic.  The sporadic papillary renal cell carcinoma is characterized by trisomy of chromosomes 7, 16, and 17, and loss of chromosome Y.  The peak incidence is in the sixth and seven decades.  It is classified as type 1 or 2, based on the cytoplasmic volume and the thickness of the lining neoplastic cells. The prognosis is more favorable than for conventional (clear cell) renal cell carcinoma. -- 2003","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Papillary Renal Cell Carcinoma","conceptCode":"C6975","definition":"Also known as chromophil carcinoma, it represents a minority of renal cell carcinomas.  It can be hereditary or sporadic.  The sporadic papillary renal cell carcinoma is characterized by trisomy of chromosomes 7, 16, and 17, and loss of chromosome Y.  The peak incidence is in the sixth and seven decades.  It is classified as type 1 or 2, based on the cytoplasmic volume and the thickness of the lining neoplastic cells. The prognosis is more favorable than for conventional (clear cell) renal cell carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0BE7-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-07","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-07","modifiedBy":"ONEDATA","dateModified":"2006-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B546673-A845-9D7F-E050-BB89AD434516","beginDate":"2015-07-20","endDate":null,"createdBy":"TSANE","dateCreated":"2015-07-20","modifiedBy":"ONEDATA","dateModified":"2015-07-20","deletedIndicator":"No"},{"value":"Ossifying renal tumor of infancy","valueDescription":"Ossifying Renal Tumor of Infancy","ValueMeaning":{"publicId":"4908804","version":"1","preferredName":"Ossifying Renal Tumor of Infancy","longName":"4908804","preferredDefinition":"A benign neoplasm of the kidney occurring in infants. It develops as an intracalyceal mass and is characterized by the presence of osteoid formation, osteoblast-like cells, and spindle cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Ossifying Renal Tumor of Infancy","conceptCode":"C66774","definition":"A benign neoplasm of the kidney occurring in infants. It develops as an intracalyceal mass and is characterized by the presence of osteoid formation, osteoblast-like cells, and spindle cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B546673-A852-9D7F-E050-BB89AD434516","latestVersionIndicator":"Yes","beginDate":"2015-07-20","endDate":null,"createdBy":"TSANE","dateCreated":"2015-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B546673-A86B-9D7F-E050-BB89AD434516","beginDate":"2015-07-20","endDate":null,"createdBy":"TSANE","dateCreated":"2015-07-20","modifiedBy":"ONEDATA","dateModified":"2015-07-20","deletedIndicator":"No"},{"value":"Oncocytic renal neoplasms following neuroblastoma","valueDescription":"Oncocytic renal neoplasms following neuroblastoma","ValueMeaning":{"publicId":"4908805","version":"1","preferredName":"Oncocytic renal neoplasms following neuroblastoma","longName":"4908805","preferredDefinition":"Oncocytic renal neoplasms following neuroblastoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B546673-A875-9D7F-E050-BB89AD434516","latestVersionIndicator":"Yes","beginDate":"2015-07-20","endDate":null,"createdBy":"TSANE","dateCreated":"2015-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B546673-A88E-9D7F-E050-BB89AD434516","beginDate":"2015-07-20","endDate":null,"createdBy":"TSANE","dateCreated":"2015-07-20","modifiedBy":"ONEDATA","dateModified":"2015-07-20","deletedIndicator":"No"},{"value":"Nephrogenic rest","valueDescription":"Nephrogenic Rest","ValueMeaning":{"publicId":"4908806","version":"1","preferredName":"Nephrogenic Rest","longName":"4908806","preferredDefinition":"Remnants of nephrogenic blastema cells in the kidney following embryonic development.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nephrogenic Rest","conceptCode":"C88537","definition":"Remnants of nephrogenic blastema cells in the kidney following embryonic development.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B546673-A89A-9D7F-E050-BB89AD434516","latestVersionIndicator":"Yes","beginDate":"2015-07-20","endDate":null,"createdBy":"TSANE","dateCreated":"2015-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B546673-A8B3-9D7F-E050-BB89AD434516","beginDate":"2015-07-20","endDate":null,"createdBy":"TSANE","dateCreated":"2015-07-20","modifiedBy":"ONEDATA","dateModified":"2015-07-20","deletedIndicator":"No"},{"value":"Nephroblastic lesion, indeterminate between rest and Wilms tumor","valueDescription":"Nephroblastic lesion, indeterminate between rest and Wilms tumor","ValueMeaning":{"publicId":"4908807","version":"1","preferredName":"Nephroblastic lesion, indeterminate between rest and Wilms tumor","longName":"4908807","preferredDefinition":"Nephroblastic lesion, indeterminate between rest and Wilms tumor","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B546673-A8BD-9D7F-E050-BB89AD434516","latestVersionIndicator":"Yes","beginDate":"2015-07-20","endDate":null,"createdBy":"TSANE","dateCreated":"2015-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B546673-A8D6-9D7F-E050-BB89AD434516","beginDate":"2015-07-20","endDate":null,"createdBy":"TSANE","dateCreated":"2015-07-20","modifiedBy":"ONEDATA","dateModified":"2015-07-20","deletedIndicator":"No"},{"value":"Metanephric Tumor (Adenoma, Adenofibroma, Stromal Tumor)","valueDescription":"Metanephric Tumor (Adenoma, Adenofibroma, Stromal Tumor)","ValueMeaning":{"publicId":"4908808","version":"1","preferredName":"Metanephric Tumor (Adenoma, Adenofibroma, Stromal Tumor)","longName":"4908808","preferredDefinition":"Metanephric Tumor (Adenoma, Adenofibroma, Stromal Tumor)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B546673-A8E0-9D7F-E050-BB89AD434516","latestVersionIndicator":"Yes","beginDate":"2015-07-20","endDate":null,"createdBy":"TSANE","dateCreated":"2015-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B546673-A8F9-9D7F-E050-BB89AD434516","beginDate":"2015-07-20","endDate":null,"createdBy":"TSANE","dateCreated":"2015-07-20","modifiedBy":"ONEDATA","dateModified":"2015-07-20","deletedIndicator":"No"},{"value":"Focal Anaplastic Nephroblastoma (Wilms Tumor)","valueDescription":"Focal Anaplastic Nephroblastoma (Wilms Tumor)","ValueMeaning":{"publicId":"4908809","version":"1","preferredName":"Focal Anaplastic Nephroblastoma (Wilms Tumor)","longName":"4908809","preferredDefinition":"Focal Anaplastic Nephroblastoma (Wilms Tumor)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B546673-A903-9D7F-E050-BB89AD434516","latestVersionIndicator":"Yes","beginDate":"2015-07-20","endDate":null,"createdBy":"TSANE","dateCreated":"2015-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B546673-A91C-9D7F-E050-BB89AD434516","beginDate":"2015-07-20","endDate":null,"createdBy":"TSANE","dateCreated":"2015-07-20","modifiedBy":"ONEDATA","dateModified":"2015-07-20","deletedIndicator":"No"},{"value":"Favorable Histology Nephroblastoma (Wilms Tumor)","valueDescription":"Favorable Histology Nephroblastoma (Wilms Tumor)","ValueMeaning":{"publicId":"4908810","version":"1","preferredName":"Favorable Histology Nephroblastoma (Wilms Tumor)","longName":"4908810","preferredDefinition":"Favorable Histology Nephroblastoma (Wilms Tumor)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B546673-A926-9D7F-E050-BB89AD434516","latestVersionIndicator":"Yes","beginDate":"2015-07-20","endDate":null,"createdBy":"TSANE","dateCreated":"2015-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B546673-A93F-9D7F-E050-BB89AD434516","beginDate":"2015-07-20","endDate":null,"createdBy":"TSANE","dateCreated":"2015-07-20","modifiedBy":"ONEDATA","dateModified":"2015-07-20","deletedIndicator":"No"},{"value":"Diffuse Hyperplastic Perilobar Nephroblastomatosis","valueDescription":"Diffuse Hyperplastic Perilobar Nephroblastomatosis","ValueMeaning":{"publicId":"4908812","version":"1","preferredName":"Diffuse Hyperplastic Perilobar Nephroblastomatosis","longName":"4908812","preferredDefinition":"A childhood condition in which abnormal tissue grows on the outer part of one or both kidneys. Diffuse hyperplastic perilobar nephroblastomatosis usually develops into Wilms tumor (a type of childhood kidney cancer) if not treated.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diffuse Hyperplastic Perilobar Nephroblastomatosis","conceptCode":"C66851","definition":"A childhood condition in which abnormal tissue grows on the outer part of one or both kidneys. Diffuse hyperplastic perilobar nephroblastomatosis usually develops into Wilms tumor (a type of childhood kidney cancer) if not treated.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B546673-A94C-9D7F-E050-BB89AD434516","latestVersionIndicator":"Yes","beginDate":"2015-07-20","endDate":null,"createdBy":"TSANE","dateCreated":"2015-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B546673-A965-9D7F-E050-BB89AD434516","beginDate":"2015-07-20","endDate":null,"createdBy":"TSANE","dateCreated":"2015-07-20","modifiedBy":"ONEDATA","dateModified":"2015-07-20","deletedIndicator":"No"},{"value":"Diffuse Anaplastic Nephroblastoma (Wilms Tumor)","valueDescription":"Diffuse Anaplastic Nephroblastoma (Wilms Tumor)","ValueMeaning":{"publicId":"4908813","version":"1","preferredName":"Diffuse Anaplastic Nephroblastoma (Wilms Tumor)","longName":"4908813","preferredDefinition":"Diffuse Anaplastic Nephroblastoma (Wilms Tumor)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B546673-A96F-9D7F-E050-BB89AD434516","latestVersionIndicator":"Yes","beginDate":"2015-07-20","endDate":null,"createdBy":"TSANE","dateCreated":"2015-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B546673-A988-9D7F-E050-BB89AD434516","beginDate":"2015-07-20","endDate":null,"createdBy":"TSANE","dateCreated":"2015-07-20","modifiedBy":"ONEDATA","dateModified":"2015-07-20","deletedIndicator":"No"},{"value":"Cystic Nephroma or Cystic Partially Differentiated Nephroblastoma","valueDescription":"Cystic Nephroma or Cystic Partially Differentiated Nephroblastoma","ValueMeaning":{"publicId":"4908814","version":"1","preferredName":"Cystic Nephroma or Cystic Partially Differentiated Nephroblastoma","longName":"4908814","preferredDefinition":"Cystic Nephroma or Cystic Partially Differentiated Nephroblastoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B546673-A992-9D7F-E050-BB89AD434516","latestVersionIndicator":"Yes","beginDate":"2015-07-20","endDate":null,"createdBy":"TSANE","dateCreated":"2015-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B546673-A9AB-9D7F-E050-BB89AD434516","beginDate":"2015-07-20","endDate":null,"createdBy":"TSANE","dateCreated":"2015-07-20","modifiedBy":"ONEDATA","dateModified":"2015-07-20","deletedIndicator":"No"},{"value":"Cellular, Classic, or Mixed Mesoblastic Nephroma","valueDescription":"Cellular, Classic, or Mixed Mesoblastic Nephroma","ValueMeaning":{"publicId":"4908815","version":"1","preferredName":"Cellular, Classic, or Mixed Mesoblastic Nephroma","longName":"4908815","preferredDefinition":"Cellular, Classic, or Mixed Mesoblastic Nephroma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B546673-A9C9-9D7F-E050-BB89AD434516","latestVersionIndicator":"Yes","beginDate":"2015-07-20","endDate":null,"createdBy":"TSANE","dateCreated":"2015-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B546673-A9E2-9D7F-E050-BB89AD434516","beginDate":"2015-07-20","endDate":null,"createdBy":"TSANE","dateCreated":"2015-07-20","modifiedBy":"ONEDATA","dateModified":"2015-07-20","deletedIndicator":"No"},{"value":"Bilateral, not biopsied","valueDescription":"Bilateral, not biopsied","ValueMeaning":{"publicId":"4908816","version":"1","preferredName":"Bilateral, not biopsied","longName":"4908816","preferredDefinition":"Bilateral, not biopsied","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B546673-A9EC-9D7F-E050-BB89AD434516","latestVersionIndicator":"Yes","beginDate":"2015-07-20","endDate":null,"createdBy":"TSANE","dateCreated":"2015-07-20","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B546673-AA05-9D7F-E050-BB89AD434516","beginDate":"2015-07-20","endDate":null,"createdBy":"TSANE","dateCreated":"2015-07-20","modifiedBy":"ONEDATA","dateModified":"2015-07-20","deletedIndicator":"No"},{"value":"Angiomyolipoma","valueDescription":"Angiomyolipoma","ValueMeaning":{"publicId":"3247908","version":"1","preferredName":"Angiomyolipoma","longName":"3247908","preferredDefinition":"A neoplasm with perivascular epithelioid cell differentiation often associated with tuberous sclerosis.  It is characterized by a mixture of epithelioid cells, smooth muscle, vessels, and mature adipose tissue.  The kidney is the most common site of involvement.  Other sites of involvement include the liver, lung, lymph nodes, and retroperitoneum.  The vast majority of cases follow a benign clinical course.  However, cases of metastatic angiomyolipomas with sarcomatoid features have been described.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Angiomyolipoma","conceptCode":"C3734","definition":"A neoplasm with perivascular epithelioid cell differentiation often associated with tuberous sclerosis.  It is characterized by a mixture of epithelioid cells, smooth muscle, vessels, and mature adipose tissue.  The kidney is the most common site of involvement.  Other sites of involvement include the liver, lung, lymph nodes, and retroperitoneum.  The vast majority of cases follow a benign clinical course.  However, cases of metastatic angiomyolipomas with sarcomatoid features have been described.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A67B3AED-048C-CE90-E040-BB89AD433EDB","latestVersionIndicator":"Yes","beginDate":"2011-06-24","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1B546673-AA0F-9D7F-E050-BB89AD434516","beginDate":"2015-07-20","endDate":null,"createdBy":"TSANE","dateCreated":"2015-07-20","modifiedBy":"ONEDATA","dateModified":"2015-07-20","deletedIndicator":"No"},{"value":"Clear Cell Sarcoma of the kidney","valueDescription":"Clear Cell Sarcoma of the Kidney","ValueMeaning":{"publicId":"3210697","version":"1","preferredName":"Clear Cell Sarcoma of the Kidney","longName":"3210697","preferredDefinition":"A rare pediatric sarcoma affecting the kidney. It is characterized by the presence of epithelioid or spindle cells forming cords or nests, separated by fibrovascular septa. This type of sarcoma frequently metastasizes to the bones.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clear Cell Sarcoma of the Kidney","conceptCode":"C4264","definition":"A rare pediatric sarcoma affecting the kidney. It is characterized by the presence of epithelioid or spindle cells forming cords or nests, separated by fibrovascular septa. It metastasizes to lung, bone, brain and soft tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-8FFE-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"1D8B24D7-FBC3-A916-E050-BB89AD434AE3","beginDate":"2015-07-20","endDate":null,"createdBy":"WONGW","dateCreated":"2015-08-17","modifiedBy":"ONEDATA","dateModified":"2015-08-17","deletedIndicator":"No"},{"value":"TFEB RT-PCR","valueDescription":"Reverse Transcriptase-Polymerase Chain Reaction TFEB Gene","ValueMeaning":{"publicId":"6369442","version":"1","preferredName":"Reverse Transcriptase-Polymerase Chain Reaction TFEB Gene","longName":"6369442","preferredDefinition":"A laboratory procedure in which an RNA strand is first transcribed into a DNA complement and then subjected to PCR amplification. Transcribing an RNA strand into a DNA complement is termed reverse transcription and is done by the enzyme reverse transcriptase.: This gene plays a role in transcription.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Reverse Transcriptase-Polymerase Chain Reaction","conceptCode":"C18136","definition":"A laboratory procedure in which an RNA strand is first transcribed into a DNA complement and then subjected to PCR amplification. Transcribing an RNA strand into a DNA complement is termed reverse transcription and is done by the enzyme reverse transcriptase.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"TFEB Gene","conceptCode":"C94761","definition":"This gene plays a role in transcription.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"71C0F5B0-E073-6DA7-E053-F662850A9E79","latestVersionIndicator":"Yes","beginDate":"2018-07-24","endDate":null,"createdBy":"LEEW","dateCreated":"2018-07-24","modifiedBy":"ONEDATA","dateModified":"2018-07-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"71C0F5B0-E08C-6DA7-E053-F662850A9E79","beginDate":"2018-07-24","endDate":null,"createdBy":"LEEW","dateCreated":"2018-07-24","modifiedBy":"ONEDATA","dateModified":"2018-07-24","deletedIndicator":"No"},{"value":"TFEB FISH","valueDescription":"Fluorescence in Situ Hybridization TFEB Gene","ValueMeaning":{"publicId":"6369443","version":"1","preferredName":"Fluorescence in Situ Hybridization TFEB Gene","longName":"6369443","preferredDefinition":"A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping.: This gene plays a role in transcription.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fluorescence In Situ Hybridization","conceptCode":"C17563","definition":"A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"TFEB Gene","conceptCode":"C94761","definition":"This gene plays a role in transcription.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"71C0F5B0-E099-6DA7-E053-F662850A9E79","latestVersionIndicator":"Yes","beginDate":"2018-07-24","endDate":null,"createdBy":"LEEW","dateCreated":"2018-07-24","modifiedBy":"ONEDATA","dateModified":"2018-07-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"71C0F5B0-E0B2-6DA7-E053-F662850A9E79","beginDate":"2018-07-24","endDate":null,"createdBy":"LEEW","dateCreated":"2018-07-24","modifiedBy":"ONEDATA","dateModified":"2018-07-24","deletedIndicator":"No"},{"value":"TFE3 RT-PCR","valueDescription":"Reverse Transcriptase-Polymerase Chain Reaction TFE3 Gene","ValueMeaning":{"publicId":"6369444","version":"1","preferredName":"Reverse Transcriptase-Polymerase Chain Reaction TFE3 Gene","longName":"6369444","preferredDefinition":"A laboratory procedure in which an RNA strand is first transcribed into a DNA complement and then subjected to PCR amplification. Transcribing an RNA strand into a DNA complement is termed reverse transcription and is done by the enzyme reverse transcriptase.: This gene plays a role in transcriptional activation. It is involved in melanogenesis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Reverse Transcriptase-Polymerase Chain Reaction","conceptCode":"C18136","definition":"A laboratory procedure in which an RNA strand is first transcribed into a DNA complement and then subjected to PCR amplification. Transcribing an RNA strand into a DNA complement is termed reverse transcription and is done by the enzyme reverse transcriptase.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"TFE3 Gene","conceptCode":"C24854","definition":"This gene plays a role in transcriptional activation. It is involved in melanogenesis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"71C0F5B0-E0BF-6DA7-E053-F662850A9E79","latestVersionIndicator":"Yes","beginDate":"2018-07-24","endDate":null,"createdBy":"LEEW","dateCreated":"2018-07-24","modifiedBy":"ONEDATA","dateModified":"2018-07-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"71C0F5B0-E0D8-6DA7-E053-F662850A9E79","beginDate":"2018-07-24","endDate":null,"createdBy":"LEEW","dateCreated":"2018-07-24","modifiedBy":"ONEDATA","dateModified":"2018-07-24","deletedIndicator":"No"},{"value":"TFE3 FISH","valueDescription":"Fluorescence in Situ Hybridization TFE3 Gene","ValueMeaning":{"publicId":"6369445","version":"1","preferredName":"Fluorescence in Situ Hybridization TFE3 Gene","longName":"6369445","preferredDefinition":"A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping.: This gene plays a role in transcriptional activation. It is involved in melanogenesis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fluorescence In Situ Hybridization","conceptCode":"C17563","definition":"A physical mapping approach that uses fluorescent tags to detect hybridization of probes within metaphase chromosomes or less condensed somatic interphase chromatin. This technique can be used for identification of chromosomal abnormalities and for gene mapping.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"TFE3 Gene","conceptCode":"C24854","definition":"This gene plays a role in transcriptional activation. It is involved in melanogenesis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"71C0F5B0-E0E5-6DA7-E053-F662850A9E79","latestVersionIndicator":"Yes","beginDate":"2018-07-24","endDate":null,"createdBy":"LEEW","dateCreated":"2018-07-24","modifiedBy":"ONEDATA","dateModified":"2018-07-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"71C0F5B0-E0FE-6DA7-E053-F662850A9E79","beginDate":"2018-07-24","endDate":null,"createdBy":"LEEW","dateCreated":"2018-07-24","modifiedBy":"ONEDATA","dateModified":"2018-07-24","deletedIndicator":"No"},{"value":"TFE3 immunohistochemistry","valueDescription":"Immunohistochemistry Staining Method TFE3 Gene","ValueMeaning":{"publicId":"6369446","version":"1","preferredName":"Immunohistochemistry Staining Method TFE3 Gene","longName":"6369446","preferredDefinition":"Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.: This gene plays a role in transcriptional activation. It is involved in melanogenesis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Immunohistochemistry Staining Method","conceptCode":"C23020","definition":"Immunohistochemical staining techniques allow for the visualization of antigens via the sequential application of a specific antibody to the antigen (primary antibody), a secondary antibody to the primary antibody and an enzyme complex with a chromogenic substrate. The enzymatic activation of the chromogen results in a visible reaction product at the antigen site. The specimen may then be counterstained and coverslipped. Results are interpreted using a light microscope and aid in the differential diagnosis of pathophysiological processes, which may or may not be associated with a particular antigen.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"TFE3 Gene","conceptCode":"C24854","definition":"This gene plays a role in transcriptional activation. It is involved in melanogenesis.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"71C0F5B0-E10B-6DA7-E053-F662850A9E79","latestVersionIndicator":"Yes","beginDate":"2018-07-24","endDate":null,"createdBy":"LEEW","dateCreated":"2018-07-24","modifiedBy":"ONEDATA","dateModified":"2018-07-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"71C0F5B0-E124-6DA7-E053-F662850A9E79","beginDate":"2018-07-24","endDate":null,"createdBy":"LEEW","dateCreated":"2018-07-24","modifiedBy":"ONEDATA","dateModified":"2018-07-24","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"4908797","version":"1","preferredName":"Diagnosis Type","preferredDefinition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.:Something distinguishable as an identifiable class based on common qualities.","longName":"C15220:C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Diagnosis","conceptCode":"C15220","definition":"The investigation, analysis and recognition of the presence and nature of disease, condition, or injury from expressed signs and symptoms; also, the scientific determination of any kind; the concise results of such an investigation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B546673-A78B-9D7F-E050-BB89AD434516","latestVersionIndicator":"Yes","beginDate":"2015-07-20","endDate":null,"createdBy":"TSANE","dateCreated":"2015-07-20","modifiedBy":"ONEDATA","dateModified":"2015-07-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B546673-A79C-9D7F-E050-BB89AD434516","latestVersionIndicator":"Yes","beginDate":"2015-07-20","endDate":null,"createdBy":"TSANE","dateCreated":"2015-07-20","modifiedBy":"TANGL","dateModified":"2018-08-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[],"AlternateNames":[{"name":"COG","type":"USED_BY","context":"COG"},{"name":"NRG","type":"USED_BY","context":"NRG"}],"ReferenceDocuments":[{"name":"Renal histological diagnosis:","type":"Preferred Question Text","description":"Renal histological diagnosis:","url":null,"context":"COG"},{"name":"COG CRF TEXT 1","type":"Alternate Question Text","description":"Diagnostic confirmation of TFE renal cell carcinoma","url":null,"context":"COG"},{"name":"CRF Text 1","type":"Alternate Question Text","description":"Pathologically (histologically or cytologically) proven diagnosis of renal cell carcinoma","url":null,"context":"NRG"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"1B546673-AA19-9D7F-E050-BB89AD434516","latestVersionIndicator":"Yes","beginDate":"2015-07-20","endDate":null,"createdBy":"TSANE","dateCreated":"2015-07-20","modifiedBy":"KENNISHM","dateModified":"2021-12-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}